argenx SE Logo

argenx SE | 1AE - Profile, Filings, Stock Info & Investor Relations Data

argenx SE | 1AE
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
Netherlands (Kingdom of the)
Founded
2008
argenx SE (1AE)

About argenx SE

argenx SE is a biotechnology company that focuses on developing immunology solutions to help patients with autoimmune diseases. The company strives to co-create innovative therapies that will make a life-changing difference for patients. Arganx SE is committed to leveraging the power of the immune system to develop therapeutic solutions for some of the toughest autoimmune diseases out there. The company has a team of highly committed professionals with expertise in medical writing, clinical development, regulatory affairs, and other related fields who work closely to drive innovation and create solutions to help patients reach their full potential.

Market Presence

Worldwide

Headquarters

Laarderhoogtweg 25
1101EB, Amsterdam
Netherlands (Kingdom of the)

argenx SE (1AE)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

argenx SE (1AE)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

argenx SE (1AE)
Stock & Investor Information

ISINs

NL0010832176
US04016X1019

LEI

7245009C5FZE6G9ODQ71

Stock Exchange Listings

Euronext Brussels

Stock Index Memberships

BEL20 STOXX Europe 600

Industry Classification